<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Copper supplements (including parenteral nutrition additive): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Copper supplements (including parenteral nutrition additive): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Copper supplements (including parenteral nutrition additive): Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="15582" href="/d/html/15582.html" rel="external">see "Copper supplements (including parenteral nutrition additive): Drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F20452800"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Coppermin [OTC] [DSC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52871186"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Micro-Cu</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F13225075"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Trace Element, Parenteral</span></li></ul></div>
<div class="block don drugH1Div" id="F53462638"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Adequate intake (AI):</b>
<b>Note:</b> Recommended intake from dietary sources (eg, breast milk, formula).</p>
<p style="text-indent:-2em;margin-left:4em;">Neonates: Oral: 200 mcg/day (~30 mcg/kg/day) (IOM 2001; NIH 2022).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition additive, maintenance requirement:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Preterm neonates: IV: 20 to 40 mcg/kg/day (ASPEN 2020; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]). <b>Note:</b> Premature neonates weighing &lt;1.5 kg may have higher daily requirements due to low body reserves and accelerated growth rate (manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:4em;">Term neonates: IV: 20 mcg/kg/day (ASPEN 2020; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]).</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F10414674"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition additive, maintenance requirement: Note:</b> Higher doses may be needed in patients with deficiency and increased requirements.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants weighing &lt;10 kg: IV: 20 mcg/kg/day (ASPEN 2020; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants and Children weighing 10 to 40 kg: IV: 20 mcg/kg/day; maximum daily dose: 500 mcg/<b>day</b> (ASPEN 2020; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]).</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents weighing &gt;40 kg: IV: 200 to 500 mcg/day (ASPEN 2020).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51090014"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, use caution; parenteral product contains aluminum.</p></div>
<div class="block dohp drugH1Div" id="F51090015"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, use caution; in patients with significant cholestasis or hepatic dysfunction, a dosage reduction (~50%) or discontinuation may be required (ASPEN [Corkins 2015]; ASPEN [Vanek 2012]); some reports suggest infants with cholestasis may become deficient when copper is reduced or eliminated from parenteral nutrition and indicated some patients may require higher doses; monitor copper levels (Corkins 2013).</p></div>
<div class="block doa drugH1Div" id="F10414675"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="15582" href="/d/html/15582.html" rel="external">see "Copper supplements (including parenteral nutrition additive): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="81863c66-ac4f-45ff-b638-ded564c6efe2">Dietary supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary supplement: Oral:</b> 2 mg daily. Maximum: 8 mg daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition additive, maintenance requirement: IV:</b> 0.3 to 0.5 mg/day (ASPEN [Vanek 2012]).</p>
<p style="text-indent:-2em;margin-left:4em;">High output intestinal fistula: Some clinicians may use twice the recommended daily allowance (ASPEN 2002).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991119"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, use caution; contains parenteral aluminum.</p></div>
<div class="block doha drugH1Div" id="F50988436"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, use caution; in patients with significant cholestasis or hepatic dysfunction, a dosage reduction (~50%) or discontinuation may be required (ASPEN [Corkins 2015]; ASPEN [Vanek 2012]).</p></div>
<div class="block adr drugH1Div" id="F13897404"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Generally well tolerated; excessive copper levels may result in the following adverse effect.</p>
<p style="text-indent:-2em;margin-left:2em;">Hepatic: Hepatic insufficiency (including hepatic necrosis)</p></div>
<div class="block coi drugH1Div" id="F10414585"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed in the manufacturer's labeling.</p></div>
<div class="block war drugH1Div" id="F10414586"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Gastrointestinal fistulae: Patients with high output intestinal fistulae may require a larger dose than the recommended daily allowance (ASPEN 2002).</p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatic impairment: Use with caution in patients with hepatic impairment (eg, impaired biliary excretion or cholestatic liver disease).</p>
<p style="text-indent:-2em;margin-left:4em;">• Wilson's disease: Administration not recommended.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Parenteral nutrition preparation: Copper ion may degrade ascorbic acid in parenteral nutrition (PN) solutions. To avoid loss, add multivitamin additives to PN solutions immediately prior to infusion or add to separate PN solution container.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register, 2002). See manufacturer's labeling.</p></div>
<div class="block foc drugH1Div" id="F10414685"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.4 mg/mL (10 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Coppermin: 5 mg [DSC] [corn free, rye free, wheat free]</p></div>
<div class="block geq drugH1Div" id="F10414477"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F16322859"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Cupric Chloride Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.4 mg/mL (per mL): $3.14 - $3.46</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52871187"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Micro-Cu: 0.4 mg/mL (10 mL)</p></div>
<div class="block admp drugH1Div" id="F52614178"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Parenteral: Not for direct IV or IM injection; must be diluted prior to administration; due to its acidic pH, direct administration of 0.4 mg/mL solution may cause tissue irritation.</p></div>
<div class="block adm drugH1Div" id="F10414679"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">IV: Must be diluted. Do not administer IM or by direct IV injection; acidic pH of the solution may cause tissue irritation.</p></div>
<div class="block sts drugH1Div" id="F10414666"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at controlled room temperature of 20°C to 25°C (68°F to 77°F). </p></div>
<div class="block usep drugH1Div" id="F53569989"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Dietary supplement (FDA approved in adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: Additive to parenteral nutrition (PN) to maintain copper serum concentrations and to prevent depletion of endogenous stores and subsequent deficiency (FDA approved in pediatric patients [age not specified] and adults).</p></div>
<div class="block mst drugH1Div" id="F13934215"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cupric sulfate may be confused with calcium gluconate</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299092"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F10486767"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block dic drugH1Div" id="F50930749"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary reference intake (IOM 2001):</b></p>
<p style="text-indent:-2em;margin-left:4em;">1 to 6 months: Adequate intake (AI): 200 mcg/day (~30 mcg/kg/day).</p>
<p style="text-indent:-2em;margin-left:4em;">7 to 12 months: AI: 220 mcg/day (~24 mcg/kg/day).</p>
<p style="text-indent:-2em;margin-left:4em;">1 to 3 years: Recommended dietary allowance (RDA): 340 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">4 to 8 years: RDA: 440 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">9 to 13 years: RDA: 700 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">14 to 18 years: RDA: 890 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">&gt;18 years: RDA: 900 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Pregnancy: RDA: 1,000 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Lactation: RDA: 1,300 mcg/day.</p></div>
<div class="block pri drugH1Div" id="F10414482"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Animal reproduction studies have not been conducted.</p></div>
<div class="block mopp drugH1Div" id="F53569990"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Copper and/or ceruloplasmin serum concentrations in patients receiving long-term parenteral nutrition (twice monthly as recommended by manufacturer), and patients with burns, cholestasis, hepatic failure, or high output GI fistulas (ASPEN [Corkins 2015]; ASPEN [Vanek 2012]; manufacturer's labeling); superoxide dismutase activity, urine copper, and free copper may be helpful; however, availability is limited in clinical practice; confirm tests are available prior to collection (Berger 2023; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]; Zemrani 2018).</p></div>
<div class="block pha drugH1Div" id="F10414667"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Copper is an essential nutrient which serves as a cofactor for serum ceruloplasmin, an oxidase necessary for proper formation of the iron carrier protein, transferrin. It also helps maintain normal rates of red and white blood cell formation and helps prevent development of deficiency symptoms: Leukopenia, neutropenia, anemia, depressed ceruloplasmin levels, impaired transferring formation, secondary iron deficiency and osteoporosis.</p></div>
<div class="block phk drugH1Div" id="F10414670"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Excretion: Bile (primarily, 80%); intestinal wall (16%); urine (4%)</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58203689"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Levoligo</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Cobre | Cobre quelato | Sidney oliveira cobre</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Alpha kupfer | Copper Bisglycinate | Cuprimit | Hypo 11a Kupfer | Kupfer | Kupfer citrat | Kupfer-glukon | Naturasan Kupfer | Nicapur Kupfer</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Kelasin cu</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Remoplexe</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Gnc copper</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Bertil's kelasin copper | Bertil's kelasin varis | Cobre</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Kelasin cu</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Solgar chelated copper</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ASPEN.2">
<a name="ASPEN.2"></a>American Society for Parenteral and Enteral Nutrition (ASPEN). Appropriate dosing for parenteral nutrition: ASPEN recommendations. http://www.nutritioncare.org/PNDosing. Updated November 17, 2020. Accessed January 10, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11841046">
<a name="11841046"></a>ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. <i>JPEN J Parenter Enteral Nutr.</i> 2002;26(1 Suppl):1-138.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/11841046/pubmed" id="11841046" target="_blank">11841046</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36335431">
<a name="36335431"></a>Berger MM, Talwar D, Shenkin A. Pitfalls in the interpretation of blood tests used to assess and monitor micronutrient nutrition status. <i>Nutr Clin Pract</i>. 2023;38(1):56-69. doi:10.1002/ncp.10924<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/36335431/pubmed" id="36335431" target="_blank">36335431</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Copper [prescribing information]. Lake Forest, IL: Hospira; September 2017.</div>
</li>
<li>
<div class="reference">
                  Copper [prescribing information]. Long Island City, NY: Freeda; received 2011.</div>
</li>
<li>
<div class="reference">
                  Copper [prescribing information]. Long Island City, NY: Freeda; received 2012.</div>
</li>
<li>
<div class="reference">
                  Copper Caps [prescribing information]. American Fork, UT: Twinlab; received 2011.</div>
</li>
<li>
<div class="reference">
                  Coppermin (copper) [prescribing information]. St. Louis, MO: The Key Company; no date.</div>
</li>
<li>
<div class="reference">
                  Corkins MR, Balint J, Bobo E, et al. <i>The A.S.P.E.N Pediatric Nutrition Support Core Curriculum</i>. Silver Spring, MD: American Society of Parenteral and Enteral Nutrition; 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22610978">
<a name="22610978"></a>Corkins MR, Martin VA, Szeszycki EE. Copper levels in cholestatic infants on parenteral nutrition. <i>JPEN J Parenter Enteral Nutr</i>. 2013;37(1):92-96. doi:10.1177/0148607112443069<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/22610978/pubmed" id="22610978" target="_blank">22610978</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Cu-5 (copper) [prescribing information]. Fayetteville, AR: Bio-Tech; no date.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30078716">
<a name="30078716"></a>Domellöf M, Szitanyi P, Simchowitz V, Franz A, Mimouni F; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Iron and trace minerals. <i>Clin Nutr</i>. 2018;37(6, pt B):2354-2359. doi:10.1016/j.clnu.2018.06.949<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/30078716/pubmed" id="30078716" target="_blank">30078716</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25057538">
<a name="25057538"></a>Institute of Medicine (IOM) (US) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academies Press; 2001. Available at <a href="https://www.ncbi.nlm.nih.gov/books/NBK222310/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK222310/</a>.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/25057538/pubmed" id="25057538" target="_blank">25057538</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NIH.1">
<a name="NIH.1"></a>National Institutes of Health (NIH). Copper: fact sheet for health professionals. <a href="https://ods.od.nih.gov/factsheets/Copper-HealthProfessional/" target="_blank">https://ods.od.nih.gov/factsheets/Copper-HealthProfessional/</a>. Updated October 18, 2022. Accessed December 1, 2023.</div>
</li>
<li>
<div class="reference">
                  Natures Plus Copper (copper) [prescribing information]. Amityville, NY: Natural Organics Laboratories, Inc.; no date.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22730042">
<a name="22730042"></a>Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract</i>. 2012;27(4):440-491.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/22730042/pubmed" id="22730042" target="_blank">22730042</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30469420">
<a name="30469420"></a>Zemrani B, McCallum Z, Bines JE. Trace element provision in parenteral nutrition in children: one size does not fit all. <i>Nutrients</i>. 2018;10(11):1819. doi:10.3390/nu10111819<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/copper-supplements-including-parenteral-nutrition-additive-pediatric-drug-information/abstract-text/30469420/pubmed" id="30469420" target="_blank">30469420</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 16823 Version 118.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
